{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:31:49Z","timestamp":1790289109471,"version":"4.1.0"},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":5347,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1993,1]]},"abstract":"<jats:p>Zuclopenthixol acetate\u2014a new injectable formulation with a duration of action of 2\u20133 days\u2014was compared with conventional intramuscular and oral formulations of haloperidol and zuclopenthixol in the initial treatment of acutely disturbed, psychotic patients. The patients were stratified into 3 diagnostic categories: acute psychoses (48 patients), mania (22 patients), and exacerbation of chronic psychoses (73 patients). The patients were rated on the Brief Psychiatric Rating Scale (BPRS), the Bech\u2010Rafaelsen Mania Rating Scale (brmas) (only manic patients) and globally on the Clinical Global Impression (CGI). The study was an open, randomized multicentre trial with a 6\u2010day treatment period. The zuclopenthixol acetate patients received 1\u20134 doses, the haloperidol patients 1\u201326 and the zuclopenthixol patients 1\u201322 doses. The assessments on the CGI showed that all 3 treatments caused a clear reduction of the severity of illness scores in all 3 diagnostic categories, with no differences between treatments. The ratings of the acute and chronic psychotic patients on the BPRS also showed significant reductions in scores with no differences between treatments. All 3 treatments caused a rapid remission of symptoms on the BRMAS. Haloperidol induced hypokinesia in significantly more patients than zuclopenthixol acetate after 24 h. Later there were no significant differences between treatments. Zuclopenthixol acetate fulfils many desires for an amended neuroleptic formulation for the initial treatment of acutely disturbed psychotic patients.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1993.tb03329.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:38:06Z","timestamp":1187872686000},"page":"48-58","source":"Crossref","is-referenced-by-count":38,"title":["A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis"],"prefix":"10.1111","volume":"87","author":[{"given":"P. C.","family":"Baastrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. G.","family":"Alhfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bjerkenstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Dencker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fensbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gravem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Eigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Brekke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Fredslund\u2010Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lybeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Morawski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nummi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Silfverhjelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Vartiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Wiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aarvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00179201"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb02759.x"},{"key":"e_1_2_1_4_2","volume-title":"Zuclopenthixol acetate and haloperidol in acute psychosic patients. A randomized multi\u2010centre study. Presented at the ECNP Congress in Gothenburg","author":"Bobon D.","year":"1989"},{"key":"e_1_2_1_5_2","volume-title":"Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology","author":"Guy W.","year":"1976"},{"issue":"326","key":"e_1_2_1_6_2","article-title":"Mini\u2010compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM\u2010III syndromes","author":"Bech P.","year":"1986","journal-title":"Acta Psychiatr Scand"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1979.tb04484.x"},{"issue":"334","key":"e_1_2_1_8_2","article-title":"The UKU side effect rating scale","volume":"1987","author":"Lingj\u00e6rde O.","year":"1987","journal-title":"A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.2307\/2528488"},{"key":"e_1_2_1_10_2","first-page":"319","article-title":"Pharmacokinetic studies on haloperidol in man","volume":"20","author":"Forsman A.","year":"1976","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_11_2","first-page":"111","article-title":"Metabolism and pharmacokinetics of antipsychotic drugs","volume":"9","author":"J\u00f6rgensen A.","year":"1986","journal-title":"Prog Drug Metab"},{"key":"e_1_2_1_12_2","first-page":"152","article-title":"Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales","volume":"86","author":"Bobon D.","year":"1986","journal-title":"Acta Psychiatr Belg"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017281"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1985.tb01273.x"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1993.tb03329.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1993.tb03329.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T07:15:34Z","timestamp":1698218134000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1993.tb03329.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1111\/j.1600-0447.1993.tb03329.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1993.tb03329.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}